What should you know about Stelara for psoriatic arthritis?

Stelara, also called ustekinumab, targets immune signals involved in inflammation. It may be considered when psoriatic arthritis causes joint symptoms or when other treatment plans have not provided enough control. It is not a cure, and improvement can take time rather than appearing after the first dose.

Your rheumatology team will consider joint pain, joint swelling, morning stiffness, skin psoriasis, previous medicines, infections, and other health conditions. The aim is to reduce inflammation, protect movement, and support daily function.

Before treatment, tell the clinician about recurring infections, tuberculosis exposure, cancer history, allergies, pregnancy plans, and every medicine or supplement. Screening and vaccination planning may be discussed before starting. Take Stelara only on the schedule prescribed and do not alter an injection because symptoms fluctuate.

Keep follow-up appointments so joint activity, skin symptoms, and possible side effects can be reviewed. Physiotherapy can complement medical treatment by maintaining strength, range of motion, and practical function.

Contact your treatment team promptly for fever, a persistent cough, painful urination, a wound that is not healing, or other signs of infection. Seek urgent help for breathing difficulty, facial swelling, severe allergic symptoms, or sudden serious illness. Ask before receiving a live vaccine while using immune-targeting treatment.

Ask why Stelara fits your pattern of psoriatic arthritis, how response will be measured, what to do after a missed dose, and which vaccines or infection checks are needed. Discuss how anti-inflammatory medication and physiotherapy may fit alongside it.